Posted by Michael Wonder on 05 Jun 2024
ICER publishes protocol for annual assessment of drug coverage policies that present barriers to fair access
5 June 2024 - This year’s analysis will include the top ten commercial formularies by covered lives, and include drugs reviewed by ICER in 2022; data obtained from payers, MMIT’s Market Access Analytics solution, and IQVIA will be leveraged to perform the analyses.
The ICER today posted a protocol outlining how it will conduct the fourth annual assessment of how well major insurers’ prescription drug coverage policies align with a set of fair access standards.
